Navigation Links
XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting

n the second half of 2007.

CUSTOM II webcast and slide presentation

XTENT will host a webcast, slide presentation and telebriefing to review the CUSTOM II data Tuesday, May 22 at 2:00p.m. EDT (at 8:00p.m. CEST). The teleconference and slide presentation can be accessed via the investor relations section of the Company's website at http://investor.xtentinc.com/events.cfm or by calling 800-361-0912 (from the U.S.), 913-981-5559 (international). Please dial in or access the website 5 to 10 minutes prior to the beginning of the call. The webcast will be archived on the website for a minimum of three months, and can be accessed at the investor relations portion of the company's website at http://investor.xtentinc.com

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device. Note: XTENT(R) Custom NX(R) DES Systems have not been approved for sale by any regulatory authority.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding XTENT's business that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically, these statements include, but are not limited to those concerning: XTENT's ability to initiate its U.S. pivotal trial in the second ha
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/29/2009)..., CHICAGO, Nov. 29 At the 9...Radiological Society of North America (RSNA) from ...icago , Siemens Healthcare will introduce its com... oncology at booth #825, East Building/Lakeside ...ve procedures for cancer therapy, the interven...
(Date:11/29/2009)..., IOWA CITY, Iowa and ST. LOUIS, Nov. 29 /PRNews...quantitative imaging software for the advanced ana...hnologies, a leader in minimally invasive delivery...he companies have signed a definitive agreement co...dobronchial lung navigation and biopsy system. ,...
(Date:11/29/2009)... CHICAGO, Nov. 29 Stimulated by th...rship Fujifilm Medical Systems USA announced today...NA) annual meeting, the formation of its Medical ... Systems, this new group will integrate all functi...ring and creates a platform for future growth. ,...
Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2Minimally Invasive Procedure for Oncology 3Minimally Invasive Procedure for Oncology 4Minimally Invasive Procedure for Oncology 5VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3Free e Learning Courseware will Allow Companies To Measure and Improve Readiness for H1N1 Companies will be able to track measure and confirm whate 60179 1Free e Learning Courseware will Allow Companies To Measure and Improve Readiness for H1N1 Companies will be able to track measure and confirm whate 60179 2Free e Learning Courseware will Allow Companies To Measure and Improve Readiness for H1N1 Companies will be able to track measure and confirm whate 60179 31 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 11 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 2African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 1African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 2
...re/ Terumo Heart, Inc. today,announced the dischar...raHeart(TM) Left Ventricular Assist System (LVAS)....rom the University of Michigan Health,System, 15 d... 62-year-old man from Livonia, Michigan, who has b...rs. He is the first U.S.,patient to receive a vent...
...rently have a study,that is falling behind with re...ools and a budget for media but still have not see... extra set of hands to help,your sites navigate th...,administrative assistance and consultation., "Th...Ann Kottcamp,President of Argonauta Communications...
Other Medicine Technology:Discharge of First U.S. DuraHeart(TM) Patient 2Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 2
(Date:11/30/2009)...30 Stryker Corporation (...nt to acquire privately held Ascent Healthcare So...g and remanufacturing of medical devices in the U....r will acquire Ascent Healthcare Solutions for $52...is conditioned on the expiration or termination of...
(Date:11/30/2009)...ls stack up , , MONDAY, Nov. 30 (HealthD...ough the U.S. Congress differ in a number of ways ... the number of uninsured Americans. , Legislati...r this month would expand coverage to 96 percent o...roposal to expand coverage to 94 percent of Americ...
(Date:11/30/2009)... a stocking stuffer that saves lives? Holiday shop...POP BANDS® , Pet Collars and Leashes because ...gifts that make a difference. , ...w would you like to give a gift this holiday seaso...dante,s super-reflective POP BANDS® made with ...
(Date:11/30/2009)... Staten Island courtroom to recreate scene of acci...ponsible for client’s accident. , ... 2009 -- A Staten Island, N.Y. jury awarded a verd...o was injured at a New York City construction site...onstruction Company et al (Index No. 102557/05, Ca...
(Date:11/30/2009)...MOUTH MEETING, Pa., Nov. 30 The Un...nced that it has signed an agreement with ECRI Ins... academic medical center members special pricing o...his agreement will offer UHC members current data ...independent nonprofit organization, is a leader in...
Breaking Medicine News(10 mins):Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 4Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 3
...Fla., Sept. 23 It,s not music or movies that,the ...art of his latest,project. A new spot on GOLF CHAN... the PGA TOUR event bearing his name and airing on...n/prnh/20080923/CLTU101 ), In the humorous spots...
...nd giving it before radiation raised death risk 20...lthDay News) -- Older men with early-stage prostat...ation seed implant therapy face a 20 percent great...sks of death from any cause linked to androgen-dep...
... Curemark is pleased to announce ...President of Operations, and member of Curemark&rs... Rye, NY (PRWEB) September 2...anagement team, effective immediately. Dr. Zinberg...
... DynaVox grant supports The ALS A...nsultation Program. The program provides educatio...with ALS, also known as Lou Gehrig,s Disease, and ...cellence. , Pittsburgh, P...
... now accepted through Coinstar Centers(R) at retai...ricans can help the,Red Cross provide disaster rel...donating their coins at the Coinstar Center at gro...e immediate,food, shelter, counseling and other as...
...or slowed time to treatment remain unclear, expert...) -- Poorer Americans, including those on Medicai...he hospital when a heart attack strikes compared t...r time-sensitive care following a heart attack, th...
Other Medicine News:Health News:Hormone Therapy Not Best for Older Prostate Cancer Patients 2Health News:Hormone Therapy Not Best for Older Prostate Cancer Patients 3Health News:Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 3Health News:Americans Urged to Support American Red Cross Disaster Relief Efforts for Hurricanes of 2008 2Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: